Association between dipeptidyl peptidase-4 inhibitor use and risk of Parkinson’s disease among patients with diabetes mellitus: a retrospective cohort study
DPP-4 inhibitors were discovered in this study to not be associated with increased PD risk. This result was confirmed when the analysis was conducted individually for the 4 investigated DPP-4 inhibitors (sitagliptin, saxagliptin, linagliptin, and vildagliptin).
Authors
- Chien‐Ying Lee (ORCID: https://orcid.org/0000-0001-8159-4645)
- Yih Yang
- Shuo‐Yan Gau (ORCID: https://orcid.org/0000-0001-8897-5635)
- Kuang‐Hua Huang (ORCID: https://orcid.org/0000-0003-4351-6202)
- Tung‐Han Tsai
Institutions
- China Medical University (TW)
- E-Da Hospital (TW)
- Chung Shan Medical University Hospital (TW)
- Chung Shan Medical University (TW)
- I-Shou University (TW)
Publication Details
- Journal
- Aging
- Published
- 2024-08-22
- DOI
- https://doi.org/10.18632/aging.206074
- Citations
- 3
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.07
Funders
- China Medical University Hospital
- China Medical University
- Chung Shan Medical University
- Chung Shan Medical University Hospital